{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:45:07Z","timestamp":1765885507862},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1331\/1544345054003868","type":"journal-article","created":{"date-parts":[[2005,5,25]],"date-time":"2005-05-25T18:30:49Z","timestamp":1117045849000},"page":"363-370","source":"Crossref","is-referenced-by-count":10,"title":["Consumers\u2019 Perceptions About Risk of and Access to Nonprescription Medications"],"prefix":"10.1016","volume":"45","author":[{"given":"G. Caleb","family":"Alexander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadiah","family":"Mohajir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David O.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/1544345054003868_bb0010","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMra011080","article-title":"Changing the status of drugs from prescription to over-the-counter availability","volume":"345","author":"Brass","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1331\/1544345054003868_bb0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1086-5802(16)30103-6","article-title":"Rx-to-OTC switches: from prescription to self-care","volume":"NS36","author":"Newton","year":"1996","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/1544345054003868_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-6296(83)80001-0","article-title":"Costs and benefits in switching from Rx to OTC","volume":"2","author":"Temin","year":"1983","journal-title":"J Health Econ"},{"key":"10.1331\/1544345054003868_bb0025","first-page":"141","article-title":"Uncertainty and the welfare economics of medical care","volume":"53","author":"Arrow","year":"1963","journal-title":"Am Econ Rev"},{"key":"10.1331\/1544345054003868_bb0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.7326\/0003-4819-125-9-199611010-00010","article-title":"Physician recommendations and patient autonomy: finding a balance between physician power and patient choice","volume":"125","author":"Quill","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1331\/1544345054003868_bb0035","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/bmj.312.7033.758","article-title":"Over the counter drugs: the interface between the community pharmacist and patients","volume":"312","author":"Bond","year":"1996","journal-title":"BMJ"},{"issue":"5 suppl 1","key":"10.1331\/1544345054003868_bb0040","first-page":"S40","article-title":"The pharmacist's role in self-care","volume":"42","author":"McCallian","year":"2002","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/1544345054003868_bb0045","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1086-5802(16)31326-2","article-title":"Pharmaceutical care in chain pharmacies: beliefs and attitudes of pharmacists and patients","volume":"41","author":"Amsler","year":"2001","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/1544345054003868_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/009286158501900211","article-title":"Criteria used by the FDA to determine what classes of drugs are suitable switch candidates","volume":"19","author":"Rheinstein","year":"1985","journal-title":"Drug Info J"},{"key":"10.1331\/1544345054003868_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2165\/00002018-199000051-00019","article-title":"Over-the-counter drugs: the issues","volume":"5","author":"Kranz","year":"1990","journal-title":"Drug Safety"},{"key":"10.1331\/1544345054003868_bb0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1008788726842","article-title":"Abuse\/misuse of non-prescription drugs","volume":"21","author":"Hughes","year":"1999","journal-title":"Pharm World Sci"},{"key":"10.1331\/1544345054003868_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1525-1497.2003.20709.x","article-title":"Usage patterns of over-the-counter phenazopyridine (pyridium)","volume":"18","author":"Shi","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1331\/1544345054003868_bb0070","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"key":"10.1331\/1544345054003868_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1353\/ken.1999.0021","article-title":"The challenge of measuring community values in ways appropriate for setting health care priorities","volume":"9","author":"Ubel","year":"1999","journal-title":"Kennedy Inst Ethics J"},{"key":"10.1331\/1544345054003868_bb0080","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0277-9536(95)00393-2","article-title":"Availability of over-the-counter drugs for arthritis in Sao Paulo, Brazil","volume":"42","author":"Ferraz","year":"1996","journal-title":"Soc Sci Med"},{"key":"10.1331\/1544345054003868_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archfami.8.4.297","article-title":"The \u201cprescription-to-OTC switch\u201d movement: its effects on antifungal vaginitis preparations","volume":"8","author":"Lipsky","year":"1999","journal-title":"Arch Fam Med"},{"key":"10.1331\/1544345054003868_bb0090","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archinte.163.14.1673","article-title":"Direct observation of requests for clinical services in office practice: what do patients want and do they get it","volume":"163","author":"Kravitz","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1331\/1544345054003868_bb0095","first-page":"487","article-title":"Pharmacists' readiness to assess consumers' over-the-counter product selections","volume":"40","author":"Taylor","year":"2000","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/1544345054003868_bb0100","first-page":"86","article-title":"Minimizing drug misuse among elders: a proposal","volume":"102","author":"Craig","year":"1987","journal-title":"Public Health Rep"},{"key":"10.1331\/1544345054003868_bb0105","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1086-5802(16)30373-4","article-title":"Community pharmacists as patient advocates: physician attitudes","volume":"38","author":"Bradshaw","year":"1998","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/1544345054003868_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2105\/AJPH.69.1.47","article-title":"Effects of written drug information on patient knowledge and compliance: a literature review","volume":"69","author":"Morris","year":"1979","journal-title":"Am J Public Health"},{"key":"10.1331\/1544345054003868_bb0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1289\/ehp.7827317","article-title":"What is hazardous? What is safe?","volume":"27","author":"Healy","year":"1978","journal-title":"Environ Health Perspect"},{"key":"10.1331\/1544345054003868_bb0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1539-6924.1997.tb00868.x","article-title":"Exploring the \u201cpsychometric paradigm\u201d: comparisons between aggregate and individual analyses","volume":"17","author":"Marris","year":"1997","journal-title":"Risk Anal"},{"key":"10.1331\/1544345054003868_bb0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1539-6924.1994.tb00064.x","article-title":"The risks of \u201cputting the numbers in context\u201d: a cautionary tale","volume":"14","author":"Freudenburg","year":"1994","journal-title":"Risk Anal"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115316812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115316812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T12:58:09Z","timestamp":1550753889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115316812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1544319115316812"],"URL":"https:\/\/doi.org\/10.1331\/1544345054003868","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}